Skip to main content
Minnesota Department of Health logo
  • Main navigation

    • Home
    • Data, Statistics, and Legislation
    • Diseases and Conditions
    • Health Care Facilities, Providers, and Insurance
    • Healthy Communities, Environment, and Workplaces
    • Individual and Family Health
    • About Us
    • News and Announcements
    • Translated Materials

Main navigation mobile

  • Data, Statistics, and Legislation
  • Diseases and Conditions
  • Health Care Facilities, Providers, and Insurance
  • Healthy Communities, Environment, and Workplaces
  • Individual and Family Health
  • About Us
  • News and Announcements
  • Translated Materials
MDH Logo

Breadcrumb

  1. Home
  2. Healthy Communities, Environment and Workplaces
  3. Commercial Tobacco Use
  4. E-cigarettes and Vaping
  5. Vaping-Associated Lung Injury
Topic Menu

Commercial Tobacco Use

  • Commercial Tobacco Use Home
  • Data and Reports
  • Get Help Quitting
  • Prevention and Treatment

Tobacco Topics

  • Behavioral Health and Commercial Tobacco
  • COVID-19 and Commercial Tobacco
  • E-cigarettes and Vaping
  • Flavored Commercial Tobacco Products
  • Menthol Commercial Tobacco Products
  • Nicotine and Nicotine Dependence
  • Secondhand Smoke and Aerosol
  • Traditional and Sacred Tobacco

Related Topics

  • Alcohol and Other Drugs
  • Asthma
  • Cancer
  • COVID-19
  • Heart Disease
  • Mental Health and Well-being
  • Opioid Overdose Prevention
  • Oral Health
  • Radon

Commercial Tobacco Use

  • Commercial Tobacco Use Home
  • Data and Reports
  • Get Help Quitting
  • Prevention and Treatment

Tobacco Topics

  • Behavioral Health and Commercial Tobacco
  • COVID-19 and Commercial Tobacco
  • E-cigarettes and Vaping
  • Flavored Commercial Tobacco Products
  • Menthol Commercial Tobacco Products
  • Nicotine and Nicotine Dependence
  • Secondhand Smoke and Aerosol
  • Traditional and Sacred Tobacco

Related Topics

  • Alcohol and Other Drugs
  • Asthma
  • Cancer
  • COVID-19
  • Heart Disease
  • Mental Health and Well-being
  • Opioid Overdose Prevention
  • Oral Health
  • Radon
Contact Info
Commercial Tobacco Prevention and Control
651-201-3535
866-901-8316 (toll-free)
tobacco@state.mn.us

Contact Info

Commercial Tobacco Prevention and Control
651-201-3535
866-901-8316 (toll-free)
tobacco@state.mn.us

Vaping-Associated Lung Injury

Vaping-Associated Lung Injury is also known as e-cigarette, or vaping, product use-associated lung injury (EVALI).

Symptoms

In Minnesota, symptoms have resulted in hospitalizations lasting from days to weeks, with some patients admitted to intensive care units. Symptoms included shortness of breath, fever, cough, vomiting and diarrhea. Some patients also reported headache, dizziness and chest pain.

People experiencing lung symptoms after vaping should seek clinical care and avoid e-cigarettes or other vaping products, as continued use may lead to worsening symptoms.

Minnesota Vaping-Associated Lung Injury Outbreak

Minnesota was one of the first states to join with federal and state partners to investigate the vaping-associated lung injury outbreak of 2019. MDH first alerted health care providers to the condition in August 2019. Minnesota’s outbreak mirrored the national outbreak. Minnesota’s cases peaked in September through October of 2019. Cases fell off until MDH wound down its emergency response in January 2020. At the end of the emergency response, Minnesota had 149 confirmed or probable cases and 3 confirmed deaths.

Cause of the Outbreak

  • National and state data from patient reports and product sample testing show tetrahydrocannabinol (THC)-containing e-cigarette, or vaping, products, particularly from informal sources like friends, family, or in-person or online dealers, are linked to most EVALI cases and play a major role in the outbreak.
  • Vitamin E acetate is strongly linked to the EVALI outbreak. Vitamin E acetate has been found in product samples tested by FDA and state laboratories and in patient lung fluid samples tested by CDC from geographically diverse states. Vitamin E acetate has not been found in the lung fluid of people that do not have EVALI.
  • However, evidence is not sufficient to rule out the contribution of other chemicals of concern, including chemicals in either THC or non-THC products, in some of the reported EVALI cases.

Source: CDC

Information for Health Care Professionals
Vaping-Associated Lung Injuries: Information for Health Professionals

Frequently Asked Questions
Frequently Asked Questions: Lung Injury Investigation

Information for Parents and Schools

  • E-cigarettes and Vaping: Resources for Parents
  • E-cigarettes and Vaping: Resources for Schools

Related Information

  • 7/24/20 Health officials suspect new cases of severe lung injuries associated with vaping
  • 3/11/20 Vaping of THC among Adults in Minnesota (PDF)
  • 10/16/19 Health officials confirm two more deaths from severe lung injuries associated with vaping
  • 10/2/19 Student survey shows vaping rates up sharply
  • 9/6/2019 Health officials report death in a patient hospitalized for vaping-related lung injury
  • 8/17/2019 CDC, states investigating severe pulmonary disease among people who use e-cigarettes
  • 8/13/2019 News Release: Minnesota identifies severe lung injury cases among teens who reported vaping
  • 8/13/2019 Health Advisory: Severe Acute Lung Disease Among Youth Who Report Vaping (PDF)
Tags
  • tobacco
Last Updated: 10/03/2022

Get email updates


Minnesota Department of Health logo

Privacy Policy
Equal Opportunity
Translated Materials
Feedback Form
About MDH
Minnesota.gov
  • Facebook
  • Twitter
  • Linked In
  • Instagram
  • Youtube
Minnesota Department of Health Minnesota Department of health print search share facebook instagram linkedin twitter youtube